Health Ministry to start Clinical Trial of Vaccines Against SARS-CoV-2 and Cholera

Kathmandu / Sept 3: The Ministry of Health and Population is to start a clinical trial of vaccine against SARS-CoV-2 and cholera. Nepal Health Research Council is set to initiate the clinical trial of mRNA and cholera vaccines against the two diseases.

A meeting of the Council of Ministers, on August 26, decided to give permission for the clinical trial of vaccines against these diseases.

Executive Director at the Council, Dr Pradeep Gyawali said the trial of both vaccines would be started in two weeks.

According to him, the clinical trial of the MRNA vaccine would be conducted at the Dharan-based BP Koirala Institute of Health Sciences (BPKIHS) and that of the cholera vaccine at Dhulikhel Hospital, Kanti Children’s Hospital and Nepalgunj medical College Nepalgunj as well as BPKIHS, in collaboration with Deurali Janata Pharmaceuticals.

The third phase of the clinical trial is being started in Nepal after the successful trial of the MRNA first and the second phase by the vaccine producing company.

Dr Gyawali shared that the mRNA vaccine against coronavirus infection produced by the Wallvacs Company of China is to be trialled in Nepal.

It is said the Company will carry out the trial on 28 thousand people and on 3,000 people in Nepal. Accordingly, the third clinical trial would be conducted in BPKIHS, Dharan. RSS

Related News

Comments are closed

TOP NEWSview all

Four-nation championship: Nepal into the final

KMC installs Pelican crossings at 36 key locations

Japan to recruit 20,000 Nepali caregivers for health sector

Mushroom industry opened in Nawalparasi

UML reminds PM to revise provisions of Cooperative Ordinance




Positive Development Media Pvt. Ltd. / Regd. No: 232 / 073-74

Newbaneshwor
Kathmandu, Nepal

4479401


Editor : Mr. Divesh J.B. Rana

Chairperson : Mr. Kishore Thapa


Counter:
Web Counter